Cargando…

NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1

The principal Epstein-Barr virus (EBV) oncoprotein, Latent Membrane Protein 1 (LMP1), is expressed in most EBV-associated human malignancies. LMP1 mimics CD40 receptor signaling to provide infected cells with constitutive NF-κB, MAP kinase, IRF7, and PI3 kinase pathway stimulation. EBV-transformed B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ersing, Ina, Bernhardt, Katharina, Gewurz, Benjamin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717723/ https://www.ncbi.nlm.nih.gov/pubmed/23793113 http://dx.doi.org/10.3390/v5061587

Ejemplares similares

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation
por: Greenfeld, Hannah, et al.
Publicado: (2015)

Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival
por: Wang, Liang Wei, et al.
Publicado: (2019)

Colocalization of Interferon Regulatory Factor 7 (IRF7) with Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
por: Kim, In-Wook, et al.
Publicado: (2006)

Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway
por: Gatto, Graziana, et al.
Publicado: (2008)

A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells
por: Ersing, Ina, et al.
Publicado: (2017)

Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling
por: Burton, Eric M., et al.
Publicado: (2022)

Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation
por: Wang, Liang Wei, et al.
Publicado: (2019)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Correction: Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling
por: Burton, Eric M., et al.
Publicado: (2022)

Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1
por: Webb, Natasha, et al.
Publicado: (2008)

Epstein–Barr virus latency programs dynamically sensitize B cells to ferroptosis
por: Burton, Eric M., et al.
Publicado: (2022)

Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
por: Valente, Robert M., et al.
Publicado: (2012)

The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB
por: Zuo, Lielian, et al.
Publicado: (2015)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

Latent Membrane Protein 1 of Epstein–Barr Virus Promotes RIG-I Degradation Mediated by Proteasome Pathway
por: Xu, Chongfeng, et al.
Publicado: (2018)

Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
por: Yoshizaki, Tomokazu, et al.
Publicado: (2018)

Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas
por: Zhang, Yi-wang, et al.
Publicado: (2014)

Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival
por: Liang, Jin Hua, et al.
Publicado: (2021)

The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer
por: Pang, Mei-Fong, et al.
Publicado: (2008)

Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation
por: Caves, Elizabeth A., et al.
Publicado: (2017)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Santisteban-Espejo, Antonio, et al.
Publicado: (2021)

Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65
por: Cai, Mingsheng, et al.
Publicado: (2023)

Assessment of the prognostic impact of the Epstein–Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease
por: Glavina-Durdov, M, et al.
Publicado: (2001)

Latent Membrane Protein 1 Is Dispensable for Epstein-Barr Virus Replication in Human Embryonic Kidney 293 cells
por: Geiser, Vicki, et al.
Publicado: (2011)

Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus Latent Membrane Protein-1
por: Dellis, Olivier, et al.
Publicado: (2009)

The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection
por: Wasil, Laura R., et al.
Publicado: (2013)

Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma
por: Yu, Ping-Hung, et al.
Publicado: (2013)

N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation
por: Gao, Xiao, et al.
Publicado: (2017)

Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A
por: DeKroon, Robert M., et al.
Publicado: (2018)

Epstein-Barr virus in gastric cancer and association with 30 bp del-latent membrane protein 1 polymorphism
por: dos Santos, Emília Rosaria Carvalho, et al.
Publicado: (2023)

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation
por: Valentine, Robert, et al.
Publicado: (2010)

Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation
por: Zhang, Yuchen, et al.
Publicado: (2020)

Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation
por: Talaty, Pooja, et al.
Publicado: (2011)

Human NF-κB1 Haploinsufficiency and Epstein–Barr Virus-Induced Disease—Molecular Mechanisms and Consequences
por: Hoeger, Birgit, et al.
Publicado: (2018)

High Levels of Epstein-Barr Virus DNA in Latently Infected Gastric Adenocarcinoma
por: Ryan, Julie L., et al.
Publicado: (2008)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
por: Kim, Kyoung-Dong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_riaavhjs54dtcbasfv3thtdcud